Skip to main content
SpringerLink
Log in

Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

An Erratum to this article was published on 01 February 2011

Abstract

In 2007 the Italian COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) study group started to assess the application in a clinical setting of the Versailles criteria for management of acromegaly complications by a first questionnaire focusing on cardiovascular co-morbidities. A further questionnaire on sleep apnea syndrome (SAS) was delivered by the COM.E.T.A. study group to 107 endocrine centers in Italy. The results of our survey suggest that SAS is a well-known comorbidity even if its estimated prevalence is lower than in the literature. Polysomnography is the preferred tool for diagnosis. Control of SAS is considered relevant both for quality of life and co-morbidities. Continuous positive airway pressure is the cornerstone of therapy, but patients’ acceptance may be critical. Control of GH/IGF-I secretion is important to improve SAS. Management of SAS requires cooperation between specialists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004, 25: 102–52.

    Article  PubMed  CAS  Google Scholar 

  2. Giustina A, Casanueva FF, Cavagnini F, et al; The Pituitary Society and The Euopean Neuroendocrine Association. Diagnosis and treatment of acromegaly complications. J EndocrinoI Invest 2003, 26: 1242–7.

    CAS  Google Scholar 

  3. Giustina A., Mancini T, Boscani PF, et al; COM.E.T.A. (COMorbidities Evaluation and Treatment inAcromegaly) Italian Study Group. Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.TA (COMorbidities Evaluation and Treatment in Acromegaly) Study. J Endocrinol Invest 2008, 31: 1–8.

    Article  Google Scholar 

  4. Grunstein RR, Ho KY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med 1991, 115: 527–32.

    Article  PubMed  CAS  Google Scholar 

  5. Grunstein RR, Ho KK, Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med 1994, 121: 478–83.

    Article  PubMed  CAS  Google Scholar 

  6. Pelttari L, Polo O, Rauhala E, et al. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clin Endocrinol (Oxf) 1995, 43: 175–82.

    Article  CAS  Google Scholar 

  7. Rosenow F, Reuter S, Deuss U, et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endocrinol 1996, 45: 563–9.

    Article  CAS  Google Scholar 

  8. Hochban W, Ehlenz K, Conradt R, Brandenburg U. Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur Respir J 1999, 14: 196–202.

    Article  PubMed  CAS  Google Scholar 

  9. Saeki N, Isono S, Nishino T, Iuchi T, Yamaura A. Sleep-disordered breathing in acromegalics—relation of hormonal levels and quantitative sleep study by means of bedside oximeter. Endocr J 1999, 46: 585–90.

    Article  PubMed  CAS  Google Scholar 

  10. Weiss V, Sonka K, Pretl M, et al. Prevalence of sleep apnea syndrome in acromegaly population. J Endocrinol Invest 2000; 23: 515–9.

    Article  PubMed  CAS  Google Scholar 

  11. Ip MS, Tan KC, Peh WC, Lam KS. Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin Endocrinol (Oxf) 2001, 55: 477–83.

    Article  CAS  Google Scholar 

  12. Dostalova S, Sonka K, Smahel Z, Weiss V, Marek J, Horinek D. Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur J Endocrinol 2001, 144: 491–7.

    Article  PubMed  CAS  Google Scholar 

  13. Herrmann BL, Wessendorf TE, Ajaj W, Kahlke S, Teschler H, Mann K. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur J Endocrinol 2004, 151: 309–15.

    Article  PubMed  CAS  Google Scholar 

  14. Sze L, Schmid C, Bloch KE, Bernays R, Brändle M. Effect of transsphenoidal surgery on sleep apnoea in acromegaly. Eur J Endocrinol 2007, 156: 321–9.

    Article  PubMed  CAS  Google Scholar 

  15. Davì MV, Dalle Carbonare L, Giustina A, et al. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol 2008, 159: 533–40.

    Article  PubMed  CAS  Google Scholar 

  16. van Haute FR, Taboada GF, Corrêa LL, et al. Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur J Endocrinol 2008, 158: 459–65.

    Article  PubMed  CAS  Google Scholar 

  17. Berg C, Wessendorf TE, Mortsch F, et al. Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly. Eur J Endocrinol 2009, 161: 829–35.

    Article  PubMed  CAS  Google Scholar 

  18. Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab 2010, 95: 483–95.

    Article  PubMed  CAS  Google Scholar 

  19. Patil SP, Schneider H, Schwartz AR, Smith PL. Adult obstructive sleep apnea: phathophysiology and diagnosis. Chest 2007, 132: 325–37.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Collop NA, Anderson WM, Boehlecke B, et al; Portable monitoring task force of the American Academy of Sleep Medicine. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patient. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007, 3: 737–47.

    PubMed  Google Scholar 

  21. Commissione paritetica AIPO-AIMS. Linee guida di procedura diagnostica nella sindrome delle apnee ostruttive dell’adulto. Rassegna di Patologia dell’Apparato respiratorio 2001, 16: 278–80.

    Google Scholar 

  22. Chervin RD, Murman DL, Malow BA, Totten V. Cost-utility of three approaches to the diagnosis of sleep apnea: polysomnography, home testing, and empirical therapy. Ann Intern Med 1999, 130: 496–505.

    Article  PubMed  CAS  Google Scholar 

  23. Fleetham J, Ayas N, Bradley D, et al; CTS Sleep Disordered Breathing Committee. Canadian Thoracic Society guidelines: diagnosis and treatment of sleep disordered breathing in adults. Can Respir J 2006, 13: 387–92.

    PubMed Central  PubMed  Google Scholar 

  24. Melmed S. Medical progress: acromegaly. N Engl J Med 2006, 355: 2558–73.

    Article  PubMed  CAS  Google Scholar 

  25. Colao A, Terzolo M, Bondanelli M, et al. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive therapy. Clin Endocrinol 2008, 69: 613–20.

    Article  Google Scholar 

  26. Calhoun DA, Jones D, Textor S, et al; American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008, 117: e510–26.

    Article  PubMed  Google Scholar 

  27. Lanfranco F, Motta G, Minetto MA, Ghigo E, Maccario M. Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update. J Endocrinol Invest 2010, 33: 192–6.

    Article  PubMed  CAS  Google Scholar 

  28. Mazziotti G, Floriani I, Bonadonna S, Torri V, Chanson P, Giustina A. Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. J Clin Endocrinol Metabol 2009, 94: 1500–8.

    Article  CAS  Google Scholar 

  29. Sardella C, Lombardi M, Rossi G, et al. Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study. J Endocrinol Invest 2010, 33: 20–5.

    Article  PubMed  CAS  Google Scholar 

  30. Perez de Llano LA, Golpe R, Ortiz Piquer M, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 2005, 128: 587–94.

    Article  PubMed  Google Scholar 

  31. Kushida CA, Chediak A, Berry RB, et al; Positive airway pressure titration task force; American Academy of Sleep Medcine. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 2008, 4: 157–71.

    PubMed  Google Scholar 

  32. Melmed S, Colao A, Barkan A, et al; Acromegaly Consensus Group. Guidelines for acromegaly management: an update. J Clin Endocrinol Metabol 2009, 94: 1509–17.

    Article  CAS  Google Scholar 

  33. De Marinis L, Bianchi A, Mazziotti G, et al. The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. Pituitary 2008, 11: 13–20.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, General Hospital, Montebelluna, Italy

    E. De Menis MD

  2. University of Brescia, Brescia, Italy

    A. Giustina

  3. University of Naples, Naples, Italy

    A. Colao

  4. University of Ferrara, Ferrara, Italy

    E. Degli Uberti

  5. University of Turin, Turin, Italy

    E. Ghigo

  6. University of Genova, Genova, Italy

    F. Minuto

  7. University of Pisa, Pisa, Italy

    F. Bogazzi

  8. General Hospital, Feltre, Italy

    R. Drigo

  9. Ipsen S.p.a., Milan, Italy

    A. Cattaneo

  10. University “A. Avogadro” of Piemonte Orientale, Novara, Italy

    G. Aimaretti

Authors
  1. E. De Menis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Giustina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Colao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Degli Uberti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Ghigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Minuto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Bogazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Drigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Cattaneo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. G. Aimaretti
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Italian Study Group

Corresponding author

Correspondence to E. De Menis MD.

Additional information

Members of the COM.E.T.A Italian Study Group are listed in the Appendix.

An erratum to this article is available at http://dx.doi.org/10.1007/BF03347054.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Menis, E., Giustina, A., Colao, A. et al. Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. J Endocrinol Invest 34, 60–64 (2011). https://doi.org/10.1007/BF03346696

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346696

Keywords

Search

Navigation